Skip to main content
Caplight Logo









Beijing Yimiao Shenzhou Pharmaceutical Technology

Beijing Yimiao Shenzhou Pharmaceutical Technology

Private
BeijingHealthcare & Life Scienceshttp://immunochina.com/

Last Round

Series G

Jan 8, 2025

Est. Valuation

$530.5M

Total Funding Raised

$173.28M

Company Overview

Beijing Yimiao Shenzhou Pharmaceutical Technology is a clinical-stage biopharmaceutical company that develops CAR-T cell therapies and gene-based medicines for the treatment of cancer and autoimmune disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

CAR-T cell therapycell therapygene therapycancer immunotherapyimmunotherapylentiviral vectorhematological malignanciessolid tumor treatmentcell engineeringGMP manufacturingbiopharmaceuticalclinical-stage biotechCDMOcontract development and manufacturing organization

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beijing Yimiao Shenzhou Pharmaceutical Technology Comparables

Compare Beijing Yimiao Shenzhou Pharmaceutical Technology with similar companies based on industry and business-model similarity.

Beijing Yimiao Shenzhou Pharmaceutical Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hrain Biotechnology Co., Ltd.
90%
Juventas Cell Therapy Ltd.
89%
IASO Bio
88%

Beijing Yimiao Shenzhou Pharmaceutical Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series GJan 8, 2025
Private EquityMay 1, 2023
Series D ExtensionOct 31, 2022
Series DNov 24, 2021
Series C ExtensionDec 22, 2020
Series C Extension
Oct 16, 2020

Beijing Yimiao Shenzhou Pharmaceutical Technology Investors

Notable investors and investment history

Beijing Yimiao Shenzhou Pharmaceutical Technology investors
InvestorRounds
China Development Bank CapitalSeries G
GF Qianhe InvestmentSeries D
Thiel CapitalSeries B, Series A
Legend CapitalSeries B
Beijing Zhongguancun Science City Innovation Development Co., Ltd.Series D Extension
北京首都科技发展集团有限公司Series A
SDIC Venture CapitalSeries C Extension, Series D, Series G

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2023

    Raised a Private Equity round.

  • Oct 31, 2022

    $28M round led by Beijing Zhongguancun Science City Innovation Development Co., Ltd.

Beijing Yimiao Shenzhou Pharmaceutical Technology Filings

Explore SEC and related filing metadata, where available.

Beijing Yimiao Shenzhou Pharmaceutical Technology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Beijing Yimiao Shenzhou Pharmaceutical Technology's valuation, stock price, and market status.

Is Beijing Yimiao Shenzhou Pharmaceutical Technology a public or private company?

Beijing Yimiao Shenzhou Pharmaceutical Technology is a private company.

What is the current stock price of Beijing Yimiao Shenzhou Pharmaceutical Technology?

Beijing Yimiao Shenzhou Pharmaceutical Technology is a private company with no public stock price. No recent secondary market data is available.

How much is Beijing Yimiao Shenzhou Pharmaceutical Technology worth (valuation)?

Beijing Yimiao Shenzhou Pharmaceutical Technology's valuation is estimated at $530.5M based on funding round data.

Can I buy Beijing Yimiao Shenzhou Pharmaceutical Technology stock?

Beijing Yimiao Shenzhou Pharmaceutical Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Beijing Yimiao Shenzhou Pharmaceutical Technology's last funding round?

Beijing Yimiao Shenzhou Pharmaceutical Technology's most recent funding round was Series G on January 8, 2025.

Who are the main investors in Beijing Yimiao Shenzhou Pharmaceutical Technology?

Key investors in Beijing Yimiao Shenzhou Pharmaceutical Technology include Legend Capital, Beijing Zhongguancun Science City Innovation Development Co., Ltd..

Will Beijing Yimiao Shenzhou Pharmaceutical Technology IPO soon?

No public IPO plans have been announced for Beijing Yimiao Shenzhou Pharmaceutical Technology.

How can I track Beijing Yimiao Shenzhou Pharmaceutical Technology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Beijing Yimiao Shenzhou Pharmaceutical Technology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeijing
Employee Range14
Year Founded2015
Last FundingJan 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?